Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet — manufactured by Trumac Healthcare

Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab)
Form: Tablet
Class: Sulphonylurea + biguanide + alpha-glucosidase inhibitor (Triple OAD SR)
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Type-2 DM with prominent post-prandial hyperglycaemia
  • Inadequate control on Glimepiride + Metformin combination
  • Patients with high carbohydrate intake patterns
Mechanism of Action

Glimepiride closes pancreatic K-ATP channels, triggering insulin secretion. Metformin activates AMPK, suppressing hepatic glucose output. Voglibose is an alpha-glucosidase inhibitor in the small-intestinal brush border, delaying breakdown of disaccharides and oligosaccharides — flattening the post-prandial glucose rise.

Dosage & Administration
  • Adults: 1 tablet at the start of breakfast
  • Voglibose must be taken with the first bite of food
  • Swallow whole
  • Monitor HbA1c and post-prandial glucose
Side Effects
  • Hypoglycaemia
  • GI flatulence and abdominal distension (voglibose)
  • GI upset (metformin)
  • Hypoglycaemia recovery requires glucose, not sucrose
Contraindications
  • Type-1 diabetes
  • Severe renal impairment
  • Severe hepatic impairment
  • Inflammatory bowel disease
  • Pregnancy and breastfeeding
Storage

Store below 25°C.

PCD Pharma Franchise for Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 10 (Blister)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet?

Available pack sizes include: 10 x 10 (Blister).

What is the MRP / trade price for Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet?

MRPs range from ₹1750 to ₹1750 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Glimepiride 2 mg + Metformin 1000 mg + Voglibose 0.3 mg (Bilayered Tab) Tablet?

Get Pricing & Franchise Terms →